Health Canada to propose regulatory change to enable consideration of applications under the Special Access Programme to facilitate treatment of chronic relapsing opioid dependence

Health Canada announced today that the department will propose a regulatory amendment to allow access to diacetylmorphine under Health Canada's Special Access Programme ("SAP").

Source: Government of Canada News - Health Canada - May 14, 2016 Category: American Health Authors: Health Canada Source Type: news